Goldman Sachs initiates Synopsys stock coverage with Buy rating

Investing.com

Published Jul 10, 2025 06:19AM ET

Goldman Sachs initiates Synopsys stock coverage with Buy rating

Investing.com - Goldman Sachs initiated coverage on Synopsys (NASDAQ:SNPS) with a Buy rating and a price target of $620.00 on Thursday. According to InvestingPro data, the company maintains impressive gross profit margins of 81.4% and demonstrates strong financial health with a GOOD overall rating.

The investment bank identified Synopsys as a "critical provider of semiconductor design software tools" with exposure to multiple growth drivers throughout the industry.

Goldman Sachs noted a broadening customer base is driving outsized growth in the company's intellectual property franchise, while physical electronic design automation (EDA) represents a meaningful growth opportunity.

The firm acknowledged ongoing potential headline risk from China export restrictions that could affect the company.

Goldman Sachs also viewed Synopsys' pending acquisition of Ansys (NASDAQ:ANSS) as a "potential strategic positive" for the company.

In other recent news, Synopsys Inc . announced the suspension of its financial guidance for the third quarter and the full fiscal year of 2025 due to new export restrictions related to China. Before this suspension, Synopsys had projected third-quarter revenue between $1.755 billion and $1.785 billion, with non-GAAP earnings per share expected to range from $3.82 to $3.87. The company also reaffirmed its full-year revenue guidance of $6.745 billion to $6.805 billion. Meanwhile, Synopsys reported strong financial results for its second fiscal quarter, with adjusted earnings per share of $3.67, surpassing analyst estimates of $3.39. The company's revenue for the quarter reached $1.604 billion, slightly above the consensus estimate and marking a 10.2% year-over-year increase. In other developments, the U.S. Department of Commerce rescinded export restrictions related to China, allowing Synopsys to restore access to previously restricted products. Additionally, Synopsys and Samsung (KS:005930) Foundry have strengthened their collaboration to advance chip designs, achieving a successful customer tape out of an HBM3 design on Samsung's SF2 process. The planned $35 billion merger between Synopsys and Ansys has been postponed by China's market regulator, following tightened chip export controls by the U.S. government.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Sign out
Are you sure you want to sign out?
NoYes
CancelYes
Saving Changes